Thursday December 8th 2011
Hosted by: Fasken Martineau
AIM - Advanced Institute of Management Research
Asia-Pacific Technology Network
This seminar will be part of the launch programme for India Inside The Emerging Innovation Challenge to the West by Nirmalya Kumar and Phanish Puranam, has just been published.
Thanks to its ability to innovate, the developed world will always have a distinct advantage over the developing world, right? Not according to leading management experts Nirmalya Kumar and Phanish Puranam. In India Inside, the authors draw on their research to show how developing-world giant India is already turning this assumption on its head—often in ways invisible to consumers in the developed world.
Through their research and extensive interviews with India based executives from numerous companies including AstraZeneca, GE, Infosys, Intel and Wipro, the authors unveil the dramatic rise in invisible innovation occurring in India—in areas such as B2B products, R&D outsourcing, as well as process and management innovation. The book also illuminates Indian companies’ growing ability to innovate consumer products that are compact, low-cost, efficient, and robust in the face of harsh environmental conditions. The authors’ analysis makes clear that for certain kinds of innovation, the long held monopoly of the developed world is over.
India Inside not only provides a wake-up call for executives and policy makers in the developed world by introducing new concepts such as “mirage of mighty labor pools”, “browning of TMT”, “the injection of intelligence” and “the sinking skill ladder”. It also offers a clear-eyed view of both the challenges and opportunities facing multinationals seeking new sources of innovation in the future, as well as the issues that Indian policy makers need to address urgently.
Nirmalya Kumar and Phanish Puranam are Professors and Co-Directors of the Aditya Birla India Centre at London Business School. They have authored numerous books and articles on marketing, innovation, strategy and Indian business.
Location: Fasken Martineau, 17 Hanover Square London W1S 1HU
Nearest tube station: Oxford Circus
Timing: Registration from 17:00: seminar from 17:30 - 19.15 (followed by refreshments)
To Register your interest- please send your details (name, institutional affiliation, email address, phone number - and the category you come under) to firstname.lastname@example.org
Professor Nirmalya Kumar
Kumar received his Bachelor of Commerce at Calcutta University in 1980, and his Masters of Commerce at Shivaji University in 1983. In 1986, he completed his MBA at the University of Illinois at Chicago and in 1991, received his Ph.D. in Market at the Kellogg School of Management in Northwestern University. Kumar is currently a Professor of Marketing and Co-Director of Aditya Birla India Centre at London Business School. He previously served on the faculty of Harvard Business School, IMD-International Institute for Management Development (Switzerland), and Kellogg School of Management at Northwestern University. He has authored five books on marketing and business-related topics. He is notable for proposing the culture of "3Vs": valued customer, value proposition and value network, explained in his book Marketing as Strategy: Understanding the CEO's Agenda for Driving Growth and Innovation.
Dr Nermeen Y. Varawalla, MD, DPhil (Oxon), MBA
Dr Nermeen Varawalla is the founder and CEO of ECCRO, a differentiated India specialist CRO for Phase II-IV international clinical trials. Dr Varawalla is an acknowledged industry expert in the conduct of international clinical trials in India and has established successful businesses in this sector. Firstly, PerinClinical which she sold to PRA International, a leading global player, following which Dr Varawalla was Vice President at PRA International. Nermeen has participated in the design & conduct of over 50 international clinical trials that have included emerging countries.
Dr Varawalla is a Fellow of the College of Physicians & Surgeons of India, was Rhodes Fellow at the University of Oxford where she obtained a doctorate for molecular genetics research and worked a specialist at two of the NHS’s leading hospitals. Dr. Varawalla obtained her MBA from INSEAD following which she joined Accenture’s Healthcare and Life Science business strategy consulting practice in London.
Dr Varawalla is a frequent invited speaker at industry conferences, serves on the editorial board of the Journal for Clinical Studies and is the Program Chair for the DIA.